US Archives - Page 48 of 80 - European Medical Journal

AMJ Microbiology & Infectious Diseases 2.1 2024

What’s redefining infectious diseases in 2024? In this issue of AMJ Microbiology & Infectious Diseases, we unpack the pivotal moments…

Cancer Screenings In HIV: Roles of Individuals and System

As persons with HIV(PWH) age, non-AIDS-defining cancers (NADC) are emerging as a leading cause of morbidity and mortality…

The Unseen Impact of Visceral Fat in HIV

While modern antiretroviral therapy (ART) for people with HIV (PWH) increases life expectancy, there is still an increased risk of…

HIV Treatment at IDWeek 2024

AT IDWeek 2024, held in Los Angeles, California, researchers converged from across the world to discuss the latest research surrounding…

Assessing HAV and HBV in HIV Within Illinois Department of Corrections

Individuals in custody face higher risks of vaccine-preventable diseases due to overcrowding, high turnover, high-risk behaviors, and…

Battling Pediatric Mold Infections: Invasive Aspergillosis and Invasive Mucormycosis

Mold species are inhaled by people every day and, typically, infection is locally curtailed by the immune system. However, in people who…

Respiratory Viral Infections: Highlights from IDWeek 2024

IDWEEK 2024, held in Los Angeles, California, October 16th–19th, was an opportunity for the >12,000 attendees to hear about…

Prescribing Behavior of Foot Wound Infection: Antimicrobial Stewardship Opportunity

The primary pathogens of soft tissue infections, including those of the foot, are beta-haemolytic Streptococci and Staphylococcus aureus…

Cardiac MRI Identifies Heart Disease Risk in Hepatitis C Irrespective of Damage Markers

Infection with hepatitis C virus (HCV) increases the risk of extrahepatic manifestations, including cardiovascular disease (CVD)…

A Case for Caution: Breaking Down Antimicrobial Resistance

AS ANTIMICROBIAL resistance grows into a global crisis, effective treatment strategies for drug-resistant infections are more essential…